QQQ   293.41 (-0.41%)
AAPL   141.83 (-1.70%)
MSFT   246.96 (-0.34%)
META   148.88 (-0.06%)
GOOGL   98.04 (-0.81%)
AMZN   101.88 (-1.21%)
TSLA   172.72 (-0.29%)
NVDA   199.99 (+2.36%)
NIO   11.69 (-3.15%)
BABA   110.78 (+0.53%)
AMD   81.11 (+7.93%)
T   20.33 (-0.20%)
MU   61.23 (+1.54%)
F   13.60 (+0.67%)
CGC   2.97 (-1.98%)
GE   81.08 (+0.75%)
DIS   107.89 (-0.55%)
AMC   5.34 (-0.19%)
PFE   43.85 (-0.70%)
PYPL   80.64 (-1.04%)
NFLX   356.14 (+0.64%)
QQQ   293.41 (-0.41%)
AAPL   141.83 (-1.70%)
MSFT   246.96 (-0.34%)
META   148.88 (-0.06%)
GOOGL   98.04 (-0.81%)
AMZN   101.88 (-1.21%)
TSLA   172.72 (-0.29%)
NVDA   199.99 (+2.36%)
NIO   11.69 (-3.15%)
BABA   110.78 (+0.53%)
AMD   81.11 (+7.93%)
T   20.33 (-0.20%)
MU   61.23 (+1.54%)
F   13.60 (+0.67%)
CGC   2.97 (-1.98%)
GE   81.08 (+0.75%)
DIS   107.89 (-0.55%)
AMC   5.34 (-0.19%)
PFE   43.85 (-0.70%)
PYPL   80.64 (-1.04%)
NFLX   356.14 (+0.64%)
QQQ   293.41 (-0.41%)
AAPL   141.83 (-1.70%)
MSFT   246.96 (-0.34%)
META   148.88 (-0.06%)
GOOGL   98.04 (-0.81%)
AMZN   101.88 (-1.21%)
TSLA   172.72 (-0.29%)
NVDA   199.99 (+2.36%)
NIO   11.69 (-3.15%)
BABA   110.78 (+0.53%)
AMD   81.11 (+7.93%)
T   20.33 (-0.20%)
MU   61.23 (+1.54%)
F   13.60 (+0.67%)
CGC   2.97 (-1.98%)
GE   81.08 (+0.75%)
DIS   107.89 (-0.55%)
AMC   5.34 (-0.19%)
PFE   43.85 (-0.70%)
PYPL   80.64 (-1.04%)
NFLX   356.14 (+0.64%)
QQQ   293.41 (-0.41%)
AAPL   141.83 (-1.70%)
MSFT   246.96 (-0.34%)
META   148.88 (-0.06%)
GOOGL   98.04 (-0.81%)
AMZN   101.88 (-1.21%)
TSLA   172.72 (-0.29%)
NVDA   199.99 (+2.36%)
NIO   11.69 (-3.15%)
BABA   110.78 (+0.53%)
AMD   81.11 (+7.93%)
T   20.33 (-0.20%)
MU   61.23 (+1.54%)
F   13.60 (+0.67%)
CGC   2.97 (-1.98%)
GE   81.08 (+0.75%)
DIS   107.89 (-0.55%)
AMC   5.34 (-0.19%)
PFE   43.85 (-0.70%)
PYPL   80.64 (-1.04%)
NFLX   356.14 (+0.64%)
NYSE:NGVT

Ingevity - NGVT Stock Forecast, Price & News

$81.76
-0.68 (-0.82%)
(As of 02/1/2023 12:28 PM ET)
Add
Compare
Today's Range
$81.42
$82.73
50-Day Range
$69.45
$82.44
52-Week Range
$56.31
$82.73
Volume
33,962 shs
Average Volume
162,941 shs
Market Capitalization
$3.06 billion
P/E Ratio
14.07
Dividend Yield
N/A
Price Target
$81.50

Ingevity MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
1.1% Downside
$81.50 Price Target
Short Interest
Bearish
1.92% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.66mentions of Ingevity in the last 14 days
Based on 4 Articles This Week
Insider Trading
Selling Shares
$194,424 Sold Last Quarter
Proj. Earnings Growth
9.28%
From $6.36 to $6.95 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.82 out of 5 stars

Basic Materials Sector

117th out of 161 stocks

Chemicals & Allied Products Industry

11th out of 15 stocks


NGVT stock logo

About Ingevity (NYSE:NGVT) Stock

Ingevity Corp. engages in the manufacture of specialty chemicals and carbon materials. It operates through the following segments: Performance Chemicals and Performance Materials. The Performance Materials segment consists of automotive technologies and process purifications product families. Automotive technologies produces automotive carbon products used in gasoline vapor emission control systems in cars, trucks, motorcycles and boats. Process purifications produce a number of activated carbon products for food, water, beverage and chemical purification applications. The Performance Chemicals segment primarily addresses applications in three product families: pavement technologies, oilfield technologies, and industrial specialties. The company was founded on March 27, 2015 and is headquartered in North Charleston, SC.

Receive NGVT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ingevity and its competitors with MarketBeat's FREE daily newsletter.

NGVT Stock News Headlines

Huge Upside Potential With "Staggering" Solar Demand
Global solar demand is "staggering" right now, according to Bloomberg. Solar installations are set to grow 30% this year alone. And the boom is just beginning, with increasing adoption of solar by commercial, non-profit, and public entities. With only 1% of commercial electricity demand served by on-site solar globally, there is HUGE opportunity for growth.
Ingevity reports third quarter 2022 financial results
Top AI Tech Stock To Watch
Today's stock market news features a Robotics stock with blue sky potential.
Here's Why Ingevity (NGVT) is a Strong Growth Stock
Ingevity (NGVT) Gains on Demand Strength and Growth Actions
Here's Why Ingevity (NGVT) Looks Ripe for Bottom Fishing
See More Headlines
Receive NGVT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ingevity and its competitors with MarketBeat's FREE daily newsletter.

NGVT Company Calendar

Last Earnings
10/27/2021
Today
2/01/2023
Next Earnings (Estimated)
2/22/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Chemicals & allied products
Sub-Industry
N/A
Previous Symbol
NASDAQ:NGVT
Employees
1,850
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$81.50
High Stock Price Forecast
$87.00
Low Stock Price Forecast
$76.00
Forecasted Upside/Downside
-0.3%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
2 Analysts

Profitability

Net Income
$118.10 million
Pretax Margin
17.66%

Debt

Sales & Book Value

Annual Sales
$1.39 billion
Cash Flow
$8.39 per share
Book Value
$17.15 per share

Miscellaneous

Free Float
37,107,000
Market Cap
$3.06 billion
Optionable
Optionable
Beta
1.78

Key Executives

  • John C. Fortson
    President, Chief Executive Officer & Director
  • Mary Dean Hall
    Chief Financial Officer & Executive Vice President
  • Stuart Edward WoodcockStuart Edward Woodcock
    Executive VP & President-Performance Materials
  • Erik Ripple
    Senior VP, Chief Growth & Innovation Officer
  • Christine Stunyo
    Chief Human Resources Officer & Senior VP













NGVT Stock - Frequently Asked Questions

Should I buy or sell Ingevity stock right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Ingevity in the last year. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" NGVT shares.
View NGVT analyst ratings
or view top-rated stocks.

What is Ingevity's stock price forecast for 2023?

2 equities research analysts have issued 1-year price targets for Ingevity's shares. Their NGVT share price forecasts range from $76.00 to $87.00. On average, they expect the company's stock price to reach $81.50 in the next year. This suggests that the stock has a possible downside of 1.1%.
View analysts price targets for NGVT
or view top-rated stocks among Wall Street analysts.

How have NGVT shares performed in 2023?

Ingevity's stock was trading at $70.44 at the beginning of 2023. Since then, NGVT stock has increased by 17.0% and is now trading at $82.39.
View the best growth stocks for 2023 here
.

When is Ingevity's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, February 22nd 2023.
View our NGVT earnings forecast
.

How were Ingevity's earnings last quarter?

Ingevity Co. (NYSE:NGVT) released its earnings results on Wednesday, October, 27th. The company reported $1.62 earnings per share for the quarter, beating analysts' consensus estimates of $1.54 by $0.08. The company had revenue of $376.80 million for the quarter, compared to analysts' expectations of $354.29 million. Ingevity had a trailing twelve-month return on equity of 36.37% and a net margin of 13.90%. Ingevity's quarterly revenue was up 13.6% on a year-over-year basis. During the same period in the prior year, the business earned $1.79 EPS.

What guidance has Ingevity issued on next quarter's earnings?

Ingevity updated its FY 2022 earnings guidance on Wednesday, November, 9th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $1.65 billion-$1.70 billion, compared to the consensus revenue estimate of $1.60 billion.

What is John Fortson's approval rating as Ingevity's CEO?

2 employees have rated Ingevity Chief Executive Officer John Fortson on Glassdoor.com. John Fortson has an approval rating of 100% among the company's employees. This puts John Fortson in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Ingevity own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Ingevity investors own include Pfizer (PFE), AbbVie (ABBV), General Electric (GE), Verizon Communications (VZ), WestRock (WRK), Abbott Laboratories (ABT), Boeing (BA), Costco Wholesale (COST), Dominion Energy (D) and Johnson & Johnson (JNJ).

What is Ingevity's stock symbol?

Ingevity trades on the New York Stock Exchange (NYSE) under the ticker symbol "NGVT."

Who are Ingevity's major shareholders?

Ingevity's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Rice Hall James & Associates LLC (0.96%), New York State Common Retirement Fund (0.46%), Allspring Global Investments Holdings LLC (0.23%), Gateway Investment Advisers LLC (0.10%), Natixis Advisors L.P. (0.09%) and Peterson Wealth Services (0.07%). Insiders that own company stock include D Michael Wilson, Diane H Gulyas, Erik Spencer Ripple, Frederick J Lynch, John C Fortson, Michael P Smith, Richard Allen White Jr, Richard B Kelson and Stuart Edward Jr Woodcock.
View institutional ownership trends
.

How do I buy shares of Ingevity?

Shares of NGVT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Ingevity's stock price today?

One share of NGVT stock can currently be purchased for approximately $82.39.

How much money does Ingevity make?

Ingevity (NYSE:NGVT) has a market capitalization of $3.08 billion and generates $1.39 billion in revenue each year. The company earns $118.10 million in net income (profit) each year or $5.81 on an earnings per share basis.

How many employees does Ingevity have?

The company employs 1,850 workers across the globe.

How can I contact Ingevity?

Ingevity's mailing address is 4920 O`Hear Avenue Suite 400, North Charleston SC, 29406. The official website for the company is www.ingevity.com. The company can be reached via phone at (843) 740-2300, via email at daniel.gallagher@ingevity.com, or via fax at 843-740-8165.

This page (NYSE:NGVT) was last updated on 2/1/2023 by MarketBeat.com Staff